These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 10846453

  • 1. [Monitoring of Ph chromosome by fluorescence in situ hybridization in chronic myeloid leukemia].
    Takahashi N, Miura I.
    Rinsho Ketsueki; 2000 Apr; 41(4):272-4. PubMed ID: 10846453
    [No Abstract] [Full Text] [Related]

  • 2. No known cause: leukemia research.
    Tecnologica; 2000 Apr; ():1, 3-6, 14. PubMed ID: 11010680
    [No Abstract] [Full Text] [Related]

  • 3. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F.
    Rev Prat; 1999 Mar 01; 49(5):464-6. PubMed ID: 10358394
    [No Abstract] [Full Text] [Related]

  • 4. [Minimal residual disease in chronic myeloid disease. A practical focus].
    Casado LF, Steegmann JL.
    Sangre (Barc); 1997 Apr 01; 42 Suppl 1():13-6. PubMed ID: 9381293
    [No Abstract] [Full Text] [Related]

  • 5. [Molecular-cytogenetic monitoring of different regimens of treatment in patients with chronic myeloid leukemia].
    Diachenko LV, Zakharova AV, Aseeva EA, Turkina AG, Khoroshko ND, Vodinskaia LA, Udovichenko AI, Domracheva EV.
    Ter Arkh; 2004 Apr 01; 76(7):41-4. PubMed ID: 15379126
    [Abstract] [Full Text] [Related]

  • 6. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia].
    Iványi JL, Marton E, Kereskai L, Kiss Z, Pajor L.
    Orv Hetil; 2000 Nov 19; 141(47):2527-33. PubMed ID: 11143285
    [Abstract] [Full Text] [Related]

  • 7. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting.
    Chang H, Sutherland R, Nayar R, Li D, Kamel-Reid S, Mile MA, Messner H, Lipton J.
    Cancer Genet Cytogenet; 2004 Jul 15; 152(2):146-8. PubMed ID: 15262435
    [Abstract] [Full Text] [Related]

  • 8. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
    Fugazza G, Miglino M, Bruzzone R, Quintino S, Gatti AM, Grasso R, Gobbi M, Frassoni F, Sessarego M.
    J Exp Clin Cancer Res; 2004 Jun 15; 23(2):295-9. PubMed ID: 15354415
    [Abstract] [Full Text] [Related]

  • 9. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G, Garuti A, Marchelli S, Miglino M, Bruzzone R, Gatti AM, Castello S, Sessarego M.
    Cancer Genet Cytogenet; 2005 Dec 15; 163(2):173-5. PubMed ID: 16337863
    [Abstract] [Full Text] [Related]

  • 10. Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia.
    Cianciulli AM, Marzano R, Merola R, Orlandi G, Petti MC, Guadagni F, Pisani F.
    Haematologica; 2004 Sep 15; 89(9):ECR37. PubMed ID: 15377489
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A, Molnár L, Nagy A, Dávid M, Alizadeh H, Kecskés M, Vidra T, Kereskai L, Pajor L, Losonczy H.
    Orv Hetil; 2000 Nov 26; 141(48):2601-4. PubMed ID: 11141958
    [Abstract] [Full Text] [Related]

  • 12. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul 26; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 13. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
    Yao B, Guo M, Pian H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar 26; 20(3):137-9. PubMed ID: 11601240
    [Abstract] [Full Text] [Related]

  • 14. Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood.
    Kolb EA, Pan Q, Ladanyi M, Steinherz PG.
    Cancer; 2003 Dec 15; 98(12):2643-50. PubMed ID: 14669284
    [Abstract] [Full Text] [Related]

  • 15. [Changing concept of conventional therapy in chronic myelogenous leukemia].
    Ueda R.
    Rinsho Ketsueki; 2000 Apr 15; 41(4):268-71. PubMed ID: 10846452
    [No Abstract] [Full Text] [Related]

  • 16. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV, Frolova OI, Marinets OV, Ogorodnikova IuS, Afanas'ev BV, Zaritskiĭ AIu.
    Vopr Onkol; 2003 Apr 15; 49(2):189-92. PubMed ID: 12785203
    [Abstract] [Full Text] [Related]

  • 17. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B, Woroniecka R, Solarska I, Kos K, Pastwińska A, Konopka L, Majewski M.
    Cancer Genet Cytogenet; 2007 Apr 15; 174(2):111-5. PubMed ID: 17452251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.